Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nicolab is a medical technology company that develops AI-driven software solutions to improve stroke care workflows and patient outcomes. Its flagship product, StrokeViewer, is a cloud-based end-to-end platform that utilizes artificial intelligence to analyze medical imaging and connect clinicians across hospital networks in real-time. By providing automated detection of large vessel occlusions and intracranial hemorrhages, Nicolab aims to reduce treatment delays and facilitate faster decision-making for acute stroke patients. The company is a spin-off from the Amsterdam University Medical Centers and maintains a strong foundation in clinical research and validation. Nicolab serves hospitals and health systems globally, with a significant presence in Europe, Australia, and the United States.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nicolab.